Two University of Kentucky Markey Cancer Center researchers have each received a Research Scholar Grant from the American ...

Hearing the words “triple-negative breast cancer” (TNBC) can be overwhelming. It’s a diagnosis that sounds heavy — not just because breast cancer itself is frightening, but because this particular ...

WHO IS NOW CANCER FREE. TRIPLE NEGATIVE BREAST CANCER REPRESENTS ABOUT 15% OF ALL BREAST CANCERS. IT CAN BE AGGRESSIVE, BUT IF FOUND EARLY, IT CAN ALSO BE TREATED WITH TRIPLE NEGATIVE. IT MEANS IT’S ...

Triple Negative Breast Cancer (TNBC) is one of the most aggressive types of breast cancer. It’s the kind of breast cancer that doesn’t have estrogen receptors, progesterone receptors, and human ...

In patients with an aggressive form of breast cancer, treatment with the antibody-drug conjugate sacituzumab govitecan plus pembrolizumab resulted in durable responses with improved progression free ...

Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant forms of breast cancer. It grows quickly, spreads early and lacks the hormone receptors that make other ...

LOS ANGELES (KABC) -- Triple-negative breast cancer continues to be the most difficult-to-treat form of breast cancer. About 10 to 15% of patients with breast cancer have this aggressive type, but a ...

Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant forms of breast cancer. It grows quickly, spreads early and lacks the hormone receptors that make other ...

A new study has identified a set of plasma proteins that can predict whether patients with triple-negative breast cancer (TNBC) will respond to immunotherapy. By analyzing blood samples from 195 TNBC ...

TNBCs rely on fatty acid oxidization (FAO) to fuel tumor growth by breaking down surrounding adipose tissue through lipolysis. Gap junctions, particularly involving GJB3 and connexin 31 (Cx31), ...